Skip to main content
Back
Watch Compare

BIO-RAD LABORATORIES, INC.

Data quality: 100%
BIO-B
NYSE Manufacturing Measuring & Analyzing Instruments
$277.00
$0.00 (0.00%)
Mkt Cap: 7.48 B
Price
$277.00
Mkt Cap
7.48 B
Day Range
$277.00 — $277.00
52-Week Range
$225.29 — $321.12
Volume
3
Open $277.00
50D / 200D Avg
$279.39
0.85% below
50D / 200D Avg
$280.40
1.21% below

Quick Summary

Key Takeaways

Revenue declined -3.04% annually over 5 years
ROE of 10.96% — decent returns on equity
Net margin of 29.42% shows strong profitability
Debt/Equity of 0.18 — conservative balance sheet
Generating 374.60 M in free cash flow
P/E of 9.84 — trading at a low valuation

Growth

Revenue Growth (5Y)
-3.04%
Below sector avg (1.82%)
Revenue (1Y)0.65%
Earnings (1Y)N/A
FCF Growth (3Y)31.01%

Quality

Return on Equity
10.96%
Above sector avg (-53.41%)
ROIC0.38%
Net Margin29.42%
Op. Margin1.83%

Safety

Debt / Equity
0.18
Below sector avg (0.31)
Current Ratio5.44
Interest Coverage0.96

Valuation

PE (TTM)
9.84
Above sector avg (-1.48)
P/B Ratio1.11
EV/EBITDA38.96
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (1364 peers)
Metric Stock Sector Median
P/E 9.8 -1.5
P/B 1.1 1.6
ROE % 11.0 -53.4
Net Margin % 29.4 -41.5
Rev Growth 5Y % -3.0 1.8
D/E 0.2 0.3

All Fundamental Metrics
Growth
Revenue Growth (1Y) 0.65% Revenue Growth (3Y) -1.66%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) -3.04% Earnings Growth (5Y) -34.96%
Profitability
Revenue (TTM) 2.58 B Net Income (TTM) 759.90 M
ROE 10.96% ROA 7.63%
Gross Margin 51.87% Operating Margin 1.83%
Net Margin 29.42% Free Cash Flow (TTM) 374.60 M
ROIC 0.38% FCF Growth (3Y) 31.01%
Safety
Debt / Equity 0.18 Current Ratio 5.44
Interest Coverage 0.96 Asset Turnover 0.26
Working Capital 2.32 B Tangible Book Value 5.77 B
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio 9.84 Forward P/E N/A
P/B Ratio 1.11 P/S Ratio 2.89
PEG Ratio N/A Forward PEG N/A
EV/EBITDA 38.96 Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield 5.01%
Market Cap 7.48 B Enterprise Value 8.28 B
Per Share
EPS (Diluted TTM) 27.85 Revenue / Share 95.71
FCF / Share 13.88 OCF / Share 19.72
EPS CAGR (1Y) N/A EPS CAGR (5Y) -33.28%
EPS CAGR (10Y) 45.55%
Efficiency
CapEx / Revenue 6.10% FCF Conversion 49.30%
SBC-Adj. FCF 316.90 M Growth Momentum 3.69

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 2.58 B 2.57 B 2.67 B 2.80 B 2.92 B
Net Income 759.90 M -1.84 B -637.32 M -3.63 B 4.25 B
EPS (Diluted) 27.85 -25.57 -21.82 -121.79 140.56
Gross Profit 1.34 B 1.38 B 1.43 B 1.57 B 1.64 B
Operating Income 47.20 M 269.00 M 337.80 M 482.62 M 489.43 M
EBITDA — — — — —
R&D Expenses 275.60 M 295.90 M 247.43 M 256.89 M 271.66 M
SG&A Expenses 844.30 M 814.00 M 841.72 M 827.83 M 879.57 M
D&A 165.40 M 151.60 M 145.90 M 137.30 M 133.80 M
Interest Expense 49.00 M 48.90 M 49.44 M 38.11 M 1.55 M
Income Tax 235.60 M -498.30 M -212.78 M -1.08 B 1.19 B

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 10.58 B 9.36 B 12.30 B 13.50 B 17.78 B
Total Liabilities 3.12 B 2.79 B 3.56 B 3.89 B 4.11 B
Shareholders' Equity 7.45 B 6.57 B 8.74 B 9.62 B 13.67 B
Total Debt 1.20 B 1.21 B 1.21 B — —
Cash & Equivalents 529.80 M 488.10 M 403.82 M 434.22 M 470.78 M
Current Assets 2.91 B 3.03 B 3.05 B 3.16 B 1.99 B
Current Liabilities 517.00 M 467.80 M 522.80 M 568.71 M 680.94 M